Hypothetical mechanism of prostaglandin E1-induced bronchoconstriction

Medical Hypotheses

Volumn 61, Issue 3, 2003, Pages 378-384

  Uchida, Kazuhide ^a   Tateda, T ^a   Takagi, S ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; PROSTAGLANDIN E1; RECEPTOR SUBTYPE;

AIRWAY CONDUCTANCE; ASTHMA; BRONCHOSPASM; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HYPERTENSION; INTRAOPERATIVE PERIOD; MAST CELL; NEUROGENIC INFLAMMATION; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE RELAXATION; SYMPATHETIC NERVE;

EID: 0041910816     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00174-9     Document Type: Article

References (62)

1. Sweatman W. J. F., Collier H. O. J. Effects of prostaglandins on human bronchial muscle. Nature 1968; 217: 69.
2. Gardiner P. J. The effects of some natural prostaglandins on isolated human circular bronchial muscle. Prostaglandins 1975; 10: 607-616.
3. 2: distribution of central and peripheral actions. J Appl Physiol 1980; 49: 521-527.
4. 2. J Pharmacol Exp Ther 1971; 178: 541-548
5. 1 produces spasmolytic effects on histamine-induced bronchoconstriction in dogs. Crit Care Med 1999; 27: 2755-2759.
6. 1 on serotonin-induced bronchoconstriction and pulmonary hypertension in dogs. Br J Anaesth 2000; 85: 460-462.
7. 1 on canine nasal vascular and airway resistances. J Pharmacol Exp Ther 1984; 228: 215-219.
8. 1 on bronchoconstriction and thrombocytopenia during collagen and arachidonate infusions and anaphylactic shock in the guinea-pig. Prostaglandins 1979; 18: 519-528.
9. 1 on bronchial reactivity to histamine. Pneumologie 1990; 44(suppl. 1): 446-448.
10. 2 on lung resistance in patients undergoing termination of pregnancy. Clin Sci 1973; 44: 17-25.
11. Weissberg R. M., Marian J., Bradshaw J. Respiratory and cardiovascular effects of prostaglandins in the conscious guinea pig. J Pharmacol Exp Ther 1976; 198: 197-208.
12. 2. J Pharmacol Exp Ther 1980; 214: 68-73.
13. 2α on the airway resistance of healthy and asthmatic man. Clin Sci Mol Med 1975; 48: 421-430.
14. 2 on airway conductance in healthy subjects and asthmatic patients. Am Rev Respir Dis 1975; 111: 313-320.
15. Szczeklik A., Mastalerz L., Nizaukowska E. et al. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med 1996; 153: 567-571.
16. Miller R. D. In: Anesthsia, 5th edn. Philadelphia: Churchill Livingstone, 2000: 1470-1490.
17. Piper P. J., Vane J. R., Wyllie J. H. Inactivation of prostaglandins by the lungs. Nature 1970; 225: 600-604.
18. 1 as a hypotensive drug during general anaesthesia. Anaesthesia 1982; 37: 530-535.
19. 1 on non-adrenergic non-cholinergic contraction in guinea-pig bronchi. Br J Pharmacol 1990; 101: 13-14.
20. 1 on neurogenic plasma extravasation in rat airways. Eur J Pharmacol 1992; 217: 31-35.
21. Sullivan T. J., Parker K. L., Stenson W. et al. Modulation of cyclic AMP in purified rat mast cells I. Responses to pharmacologic, metabolic, and physical stimuli. J Immunol 1975; 114: 1473-1479.
22. Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 1973; 246: 215-217.
23. Laitinen L. A., Laitinen A., Widdicombe J. Effects of inflammatory and other mediators on airway vascular beds. Am Rev Respir Dis 1987; 135: S67-S70.
24. Kiriyama M., Ushikubi F., Kobayashi T. et al. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997; 122: 217-224.
25. Murata T., Ucshikubi F., Matsuoka T. et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997; 388: 678-682.
26. Ueno A., Naraba H., Ikeda Y. et al. Intrinsic prostacyclin contributes to exudation induced by bradykinin or carrageenin: a study on the paw edema induced in IP-receptor-deficient mice. Life Sci 2000; 66: PL155-PL160.
27. Hardy C. C., Bradding P., Robinson C. et al. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol 1988; 64: 1567-1574.
28. Barnes P. J. Neural control of human airway in health and disease. Am Rev Respir Dis 1986; 134: 1289-1314.
29. Barnes P. J. The third nervous system in the lung: physiology and clinical perspectives. Thorax 1984; 39: 561-567.
30. Maggi C. A. The effects of tachykinins on inflammatory and immune cells. Regul Pept 1997; 70: 75-90.
31. 2. J Appl Physiol 1985; 58: 1823-1831.
32. Nishigaki N., Negishi M., Sugimoto Y. et al. Characterization of the prostaglandin E receptor expressed on a cultured mast cell line, BNu-2cl3. Biochem Pharmacol 1993; 46: 863-869.
33. Leal-Berumen I., O'Byrne P., Gupta A. et al. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. J Immunol 1995; 154: 4759-4767.
34. 3-dependent mechanism. J Immunol 2000; 165: 6545-6552.
35. Crunkhorn P., Willis A. L. Cutaneous reactions to intradermal prostaglandins. Br J Pharmacol 1971; 41: 49-56.
36. 2 in healthy volunteers: a double blind investigation. Br J Clin Pharmacol 1987; 24: 753-761.
37. Pickles V. R. The prostaglandins. Biol Rev 1967; 42: 614-652.
38. 1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. Transplantation 1997; 64: 1514-1520.
39. 1 is able to increase migration of leukocytes through endothelial cell monolayers. Microvasc Res 2000; 59: 354-360.
40. Matsuda K., Niitsuma A., Uchida M. K. et al. Inhibitory effects of sialic acid- or N-acetylglucosamine-specific lectins on histamine release induced by compound 48/80, bradykinin and a polyethylenimine in rat peritoneal mast cells. Jpn J Pharmacol 1994; 64: 1-8.
41. Vietinghoff G., Paegelow I., Reissmann S. Induction of histamine release from rat mast cells by bradykinin analogues. Peptides 1996; 17: 1467-1470.
42. Cross L. J. M., Heaney L. G., Ennis M. Histamine release from human bronchoalveolar lavage mast cells by neurokinin A and bradykinin. Inflamm Res 1997; 46: 306-309.
43. Sharma J. N., Mohsin S. S. J. The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system. Exp Pathol 1990; 38: 73-96.
44. Ford R. P., Esnouf M. P., Burgess A. I. et al. An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma. J Immunoassay 1996; 17: 119-131.
45. Coppola R., Cristilli P., Cugno M. et al. Measurement of activated factor XII in health and disease. Blood Coagul Fibrinolysis 1996; 7: 530-535.
46. 1 infusion in anaesthetized dogs and its relation to natriuresis and diuresis. J Physiol 1977; 273: 459-474.
47. Vinci J. M., Gill J. R., Bowden R. E. et al. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition. J Clin Invest 1978; 61: 1671-1682.
48. Lechi A., Mantero F., Opocher G. et al. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult. J Endocrinol Invest 1981; 4: 17-20.
49. Ichinose M., Nakajima N., Takahashi T. et al. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992; 340: 1248-1251.
50. Kuroiwa C., Umeno E., Nogami H. et al. Role of tachykinins in bronchoconstriction induced by intravenous administration of bradykinin in guinea-pigs. Eur Respir J 1996; 9: 741-746.
51. 4. Pulm Pharmacol Ther 2000; 13: 181-188.
52. Fuller R. W., Dixon C. M. S., Cuss F. M. C. et al. Bradykinin-induced bronchoconstriction in humans. Am Rev Respir Dis 1987; 135: 176-180.
53. B receptor mRNA in bronchial biopsies from patients with asthma and chronic airway obstruction. Eur J Pharmacol 1999; 365: R1-R3.
54. Sears M. R., Burrows B., Flannery E. M. et al. Belation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. New Engl J Med 1991; 325: 1067-1071.
55. Hamelmann E., Tadeda K., Oshiba A. et al. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness - a murine model. Allergy 1999; 54: 297-305.
56. Ichinose M., Miura M., Tomaki M. et al. Incubation with IgE increases cholinergic neurotransmission in human airways in vitro. Am J Respir Crit Care Med 1996; 154: 1272-1276.
57. Ito K., Sakamoto T., Hayashi Y. et al. Role of tachykinin and bradykinin receptors and mast cells in gaseous formaldehyde-induced airway microvascular leakage in rats. Eur J Pharmacol 1996; 307: 291-298.
58. West J. V. Acute upper airway infections. Br Med Bull 2002; 61: 215-230.
59. Gwaltney J. M., Jr Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112(suppl. 6A): 13S-18S.
60. Folkerts G., van Esch B., Janssen M. et al. Virus-induced airway hyperresponsiveness in guinea pigs in vivo: study of broncho-alveolar cell number and activity. Eur J Pharmacol 1992; 228: 219-227.
61. de Kluijver J., Grunberg K., Sont J. K. et al. Rhinovirus infection in nonasthmatic subjects: effects on Intrapulmonary airway. Eur Respir J 2002; 20: 274-279.
62. Sterk P. J. Virus-induced airway hyperresponsiveness in man. Eur Respir J 1993; 6: 894-902.